| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.48▲ | 5.45▲ | 5.45▲ | 5.33▲ | 9.35▼ |
| MA10 | 5.42▲ | 5.29▲ | 5.28▲ | 5.41▲ | 5.46▲ |
| MA20 | 5.20▲ | 5.16▲ | 5.21▲ | 8.68▼ | 3.17▲ |
| MA50 | 5.14▲ | 5.66▼ | 6.80▼ | 5.54▼ | 2.05▲ |
| MA100 | 6.20▼ | 8.74▼ | 9.94▼ | 3.24▲ | 8.95▼ |
| MA200 | 9.56▼ | 8.23▼ | 5.72▼ | 2.27▲ | 937.04▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.045▲ | 0.123▲ | 0.199▲ | -0.629▼ | 0.661▲ |
| RSI | 59.764▲ | 52.566▲ | 45.992▼ | 41.082▼ | 54.226▲ |
| STOCH | 69.134 | 73.568 | 74.092 | 18.665▼ | 43.328 |
| WILL %R | -26.582 | -26.582 | -25.610 | -88.757▼ | -79.231▼ |
| CCI | 71.204 | 91.007 | 93.184 | -41.114 | 14.563 |
|
Friday, August 15, 2025 05:19 AM
MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it ...
|
|
Friday, August 15, 2025 12:38 AM
Nuwellis Inc (NUWE) navigates operational hurdles with strategic transitions and growth in pediatrics, despite a decline in overall revenue.
|
|
Thursday, August 14, 2025 11:38 AM
Discover key insights from Nuwellis' Q2 2025 earnings call. Learn about growth drivers in pediatrics, cardiac care, and outpatient heart failure programs.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 5.50 | 5.89 | 5.25 | 5.54 | 115,957 |
| 14/08/25 | 5.50 | 5.66 | 5.1106 | 5.64 | 345,959 |
| 13/08/25 | 4.91 | 5.54 | 4.903 | 5.50 | 99,985 |
| 12/08/25 | 4.92 | 5.03 | 4.87 | 4.99 | 43,192 |
| 11/08/25 | 5.10 | 5.13 | 4.87 | 4.96 | 71,783 |
| 08/08/25 | 5.10 | 5.2731 | 5.10 | 5.20 | 37,650 |
| 07/08/25 | 5.18 | 5.5585 | 5.18 | 5.27 | 55,479 |
| 06/08/25 | 5.09 | 5.25 | 5.09 | 5.20 | 62,188 |
| 05/08/25 | 5.10 | 5.435 | 4.82 | 5.21 | 891,957 |
| 04/08/25 | 8.80 | 9.03 | 6.4538 | 6.61 | 451,162 |
|
|
||||
|
|
||||
|
|